NCAM1 and acute promyelocytic leukemia: The present study investigated the efficacy of flow cytometric analysis for detecting CD2+, CD56+, and CD34+ APL immunophenotypes and other immune markers as diagnostic tools and predictors of early death and long-term prognosis in APL.